Our results suggest that DPYSL2 binds to PKM2 and inhibits the formation of tetrameric PKM2, which in turn promotes EMT and aerobic glycolysis in bladder cancer cells. This evidence concerns the gene DPYSL2 and urinary bladder carcinoma.